Spirit Pharmaceuticals Announces Exclusive ANDA OTC Partnership With Unique Pharmaceuticals Ltd./THINQ Pharmaceuticals, Singapore

Partnership includes ANDA OTC products including Cetirizine, Fexofenadine and Loratadine and other significant OTC products coming in the near future.

PRESS RELEASE  APR 5, 2021 13:00 EDT

HAUPPAUGE, N.Y., April 5, 2021 (Newswire.com) – Spirit Pharmaceuticals LLC., a leading supplier of Over the Counter (OTC) Pharmaceuticals, announces an OTC product partnership with Unique Pharmaceutical, Ltd./THINQ Pharmaceuticals, Singapore, for the U.S. retail industry. This partnership includes such products as Cetirizine, Fexofenadine and Loratadine, as of date, and other significant OTC products coming in the near future.

Mr. Malaiappan, Managing Director of THINQ Singapore, states, “We are very happy to form a strategic relationship with Spirit Pharmaceuticals and utilize their expertise to bring our OTC products to the U.S. retail market. Spirit has knowledge of the U.S. market space, a strong reputation for service, and various packaging capabilities on U.S. soil to cater to all major store brands. We are supporting Unique Pharmaceuticals Ltd., our manufacturing partner in their backward integration strategy for these OTC products.”

Ajoy Joshi, CEO of Spirit Pharmaceuticals, comments, “We are excited for this valuable Partnership which enables Spirit to bring OTC ANDAs to market that are either vertically integrated or in the process thereof, from the active pharmaceutical ingredients (API) to the finished product.” He adds, “We already know the importance that vertically integrated products provide as we are structured similarly and hold the leadership position in our APAP store brand business. We are very confident that we can serve our customers the highest quality products at a competitive cost while ensuring uninterrupted supply through global disruptions.”

About Spirit Pharmaceuticals:

Spirit Pharmaceuticals is a family-owned, leading supplier of Private Brand OTC products located in Ronkonkoma, New York. Spirit is known to continuously add to their portfolio of offerings, serving new markets and categories. Our goal is to provide our customers with consistent innovation and build consumer loyalty while offering tremendous efficiencies throughout the supply chain.

Source: Spirit Pharmaceuticals LLC